CDK2 and breast cancer: Previous studies have also shown that inhibition of CDK2/9 in triple-negative BC cells and CDK9 inhibition in osteosarcoma cells decreased migration by preventing phosphorylation of CDK-mediated Smad3 and RNA POL-ll in triple-negative BC33,34.